📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch. (2021)

First Author: O'Cathail SM
Attributed to:  Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/antiox10091380

PubMed Identifier: 34573012

Publication URI: http://europepmc.org/abstract/MED/34573012

Type: Journal Article/Review

Volume: 10

Parent Publication: Antioxidants (Basel, Switzerland)

Issue: 9

ISSN: 2076-3921